$377 Million is the total value of Iron Triangle Partners LP's 23 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BSX | New | BOSTON SCIENTIFIC CORP | $33,456,000 | – | 739,842 | +100.0% | 8.87% | – |
| ZBH | New | ZIMMER BIOMET HLDGS INC | $29,287,000 | – | 195,664 | +100.0% | 7.76% | – |
| EHC | New | ENCOMPASS HEALTH CORP | $27,477,000 | – | 396,670 | +100.0% | 7.28% | – |
| ILMN | New | ILLUMINA INC | $27,369,000 | – | 82,500 | +100.0% | 7.25% | – |
| HCA | New | HCA HEALTHCARE INC | $22,911,000 | – | 155,000 | +100.0% | 6.07% | – |
| HUM | New | HUMANA INC | $21,990,000 | – | 59,997 | +100.0% | 5.83% | – |
| BMY | New | BRISTOL MYERS SQUIBB CO | $19,257,000 | – | 300,000 | +100.0% | 5.10% | – |
| HZNP | New | HORIZON THERAPEUTICS PUB LTD | $17,676,000 | – | 488,298 | +100.0% | 4.68% | – |
| NVST | New | ENVISTA HLDGS CORP | $17,667,000 | – | 596,064 | +100.0% | 4.68% | – |
| ANTM | New | ANTHEM INC | $16,612,000 | – | 55,000 | +100.0% | 4.40% | – |
| CERN | New | CERNER CORPcall | $14,678,000 | – | 200,000 | +100.0% | 3.89% | – |
| RGEN | New | REPLIGEN CORP | $13,875,000 | – | 150,000 | +100.0% | 3.68% | – |
| MCK | New | MCKESSON CORP | $13,832,000 | – | 100,000 | +100.0% | 3.67% | – |
| EXAS | New | EXACT SCIENCES CORP | $12,938,000 | – | 139,900 | +100.0% | 3.43% | – |
| CNC | New | CENTENE CORP DEL | $12,574,000 | – | 200,000 | +100.0% | 3.33% | – |
| INOV | New | INOVALON HLDGS INC | $11,926,000 | – | 633,708 | +100.0% | 3.16% | – |
| GH | New | GUARDANT HEALTH INC | $11,282,000 | – | 144,378 | +100.0% | 2.99% | – |
| NVRO | New | NEVRO CORP | $10,500,000 | – | 89,333 | +100.0% | 2.78% | – |
| ISRG | New | INTUITIVE SURGICAL INC | $10,246,000 | – | 17,333 | +100.0% | 2.72% | – |
| TWST | New | TWIST BIOSCIENCE CORP | $10,146,000 | – | 483,144 | +100.0% | 2.69% | – |
| DXCM | New | DEXCOM INC | $10,004,000 | – | 45,734 | +100.0% | 2.65% | – |
| SNY | New | SANOFIsponsored adr | $7,139,000 | – | 142,220 | +100.0% | 1.89% | – |
| ADPT | New | ADAPTIVE BIOTECHNOLOGIES COR | $4,488,000 | – | 150,000 | +100.0% | 1.19% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| HORIZON THERAPEUTICS PUB LTD | 12 | Q3 2022 | 9.0% |
| GUARDANT HEALTH INC | 12 | Q3 2022 | 6.1% |
| CHARLES RIV LABS INTL INC | 11 | Q1 2023 | 7.8% |
| SURGERY PARTNERS INC | 11 | Q2 2023 | 6.4% |
| ICON PLC | 10 | Q3 2023 | 11.7% |
| BOSTON SCIENTIFIC CORP | 10 | Q3 2023 | 8.9% |
| NEVRO CORP | 10 | Q1 2022 | 6.7% |
| DEXCOM INC | 10 | Q3 2023 | 7.7% |
| ABBVIE INC | 9 | Q3 2023 | 8.1% |
| ACADIA HEALTHCARE COMPANY IN | 9 | Q3 2023 | 7.9% |
View Iron Triangle Partners LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View Iron Triangle Partners LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.